I-MAB

+$0.36 (+3.00%) Today
+$0.10 (+0.81%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell I-MAB and other ETFs, options, and stocks.

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China.

CEO
Jing Wu Zang
Employees
378
Headquarters
Pudong, Shanghai
Founded
2016

IMAB Key Statistics

Market cap
1.02B
Price-Earnings ratio
Dividend yield
Average volume
808.77K
High today
$12.53
Low today
$11.71
Open price
$12.31
Volume
593.33K
52 Week high
$85.40
52 Week low
$8.05

IMAB Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected Aug 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure